Search results

Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults

Type

Highly specialised technologies guidance

Published

21 October 2020

Evidence-based recommendations on Axonics sacral neuromodulation system for treating refractory overactive bladder

Type

Medical technologies guidance

Published

03 September 2020

Evidence-based recommendations on SEM Scanner 200 for preventing pressure ulcers

Type

Medical technologies guidance

Published

14 October 2020

Evidence-based recommendations on Zio XT for detecting cardiac arrhythmias

Type

Medical technologies guidance

Published

01 December 2020

Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy

Type

Medical technologies guidance

Published

11 February 2020

Evidence-based recommendations on PneuX to prevent ventilator-associated pneumonia

Type

Medical technologies guidance

Published

08 April 2020

Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia

Type

Medical technologies guidance

Published

24 June 2020

Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C

Type

Medical technologies guidance

Last updated

17 January 2020

Evidence-based recommendations on the PLASMA system for transurethral resection and haemostasis of the prostate

Type

Medical technologies guidance

Published

06 January 2021

Evidence-based recommendations on reducing the risk of Creutzfeldt–Jakob disease (CJD) transmission from surgical instruments used for interventional procedures

Type

Interventional procedures guidance

Published

22 January 2020

Evidence-based recommendations on fetoscopic prenatal repair of open neural tube defects in the fetus

Type

Interventional procedures guidance

Published

29 January 2020

Evidence-based recommendations on open prenatal repair of open neural tube defects in the fetus

Type

Interventional procedures guidance

Published

29 January 2020

Evidence-based recommendations on cyanoacrylate glue occlusion for varicose veins. This involves injecting medical glue (cyanoacrylate) into a vein to close it

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy in adults and children. This involves inserting a

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on selective internal radiation therapy for unresectable colorectal metastases in the liver in adults. This involves injecting

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on artificial iris insertion for acquired aniridia. This involves inserting an artificial iris into the eye

Type

Interventional procedures guidance

Published

22 July 2020

Evidence-based recommendations on artificial iris insertion for congenital aniridia. This involves inserting an artificial iris into the eye

Type

Interventional procedures guidance

Published

22 July 2020

Evidence-based recommendations on deep brain stimulation for refractory epilepsy in adults. This involves implanting an electrical stimulator in the brain

Type

Interventional procedures guidance

Published

12 August 2020

Evidence-based recommendations on vagus nerve stimulation for treatment-resistant depression in adults. This involves implanting an electrical stimulator under

Type

Interventional procedures guidance

Published

12 August 2020

Evidence-based recommendations on transcranial magnetic stimulation for obsessive-compulsive disorder in adults. This involves pulsing electromagnetic energy

Type

Interventional procedures guidance

Published

05 August 2020

Evidence-based recommendations on electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney

Type

Interventional procedures guidance

Published

05 August 2020

Evidence-based recommendations on bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse in adults

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on transcranial magnetic stimulation for auditory hallucinations. This involves stimulating the brain with pulses of

Type

Interventional procedures guidance

Published

23 September 2020

Evidence-based recommendations on intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention in adults. This involves

Type

Interventional procedures guidance

Published

24 June 2020

Evidence-based recommendations on pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in adults. This involves spraying the inside of

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on balloon cryoablation for Barrett’s oesophagus. This involves using a balloon filled with cold gas to destroy abnormal cells

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on balloon cryoablation for squamous dysplasia of the oesophagus. This involves using a balloon filled with cold gas to destroy

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on swallowable gastric balloon capsules for weight loss in adults. This involves swallowing a capsule containing a balloon that

Type

Interventional procedures guidance

Published

18 November 2020

Evidence-based recommendations on using drug-eluting stents in adults

Type

Technology appraisal guidance

Last updated

18 November 2020

Evidence-based recommendations on alemtuzumab (Lemtrada) for treating highly active relapsing–remitting multiple sclerosis in adults.

Type

Technology appraisal guidance

Last updated

17 March 2020

Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for treating type 1 diabetes not controlled by insulin therapy alone in adults with a

Type

Technology appraisal guidance

Last updated

12 February 2020

Evidence-based recommendations on peginterferon beta-1a (Plegridy) for treating relapsing–remitting multiple sclerosis in adults

Type

Technology appraisal guidance

Published

19 February 2020

NICE is unable to make a recommendation on recombinant human parathyroid hormone for treating hypoparathyroidism because Shire Pharmaceuticals

Type

Technology appraisal guidance

Published

04 March 2020

Evidence-based recommendations on avatrombopag (Doptelet) for treating severe thrombocytopenia in adults with chronic liver disease needing a planned invasive

Type

Technology appraisal guidance

Published

24 June 2020

Evidence-based recommendations on lenalidomide (Revlimid) with rituximab for previously treated follicular lymphoma (grade 1 to 3A) in adults

Type

Technology appraisal guidance

Published

07 April 2020

Evidence-based recommendations on lorlatinib (Lorviqua) for previously treated ALK-positive advanced non-small-cell lung cancer in adults

Type

Technology appraisal guidance

Published

13 May 2020

Evidence-based recommendations on obinutuzumab (Gazyvaro) with bendamustine for follicular lymphoma that has not responded or has progressed up to 6 months

Type

Technology appraisal guidance

Published

13 May 2020

Evidence-based recommendations on sotagliflozin with insulin for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2

Type

Technology appraisal guidance

Published

12 February 2020

Evidence based recommendations on patiromer (Veltassa) for treating hyperkalaemia in adults

Type

Technology appraisal guidance

Published

13 February 2020

Evidence-based recommendations on galcanezumab (Emgality) for preventing migraine in adults

Type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on darolutamide (Nubeqa) for treating hormone-relapsed prostate cancer in adults at high risk of developing metastatic disease

Type

Technology appraisal guidance

Published

25 November 2020

Evidence-based recommendations on pembrolizumab (Keytruda) for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC) in a

Type

Technology appraisal guidance

Published

25 November 2020

NICE is unable to make a recommendation on durvalumab (Imfinzi) in combination for untreated extensive-stage small-cell lung cancer in adults because AstraZenec

Type

Technology appraisal guidance

Published

25 November 2020

Evidence-based recommendations on venetoclax (Venclyxto) with obinutuzumab for untreated chronic lymphocytic leukaemia in adults

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on liraglutide (Saxenda) for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on upadacitinib (Rinvoq) for severe active rheumatoid arthritis in adults

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on larotrectinib (Vitrakvi) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and

Type

Technology appraisal guidance

Published

27 May 2020

Evidence-based recommendations on fremanezumab (Ajovy) for preventing chronic migraine in adults

Type

Technology appraisal guidance

Published

03 June 2020

Evidence-based recommendations on ustekinumab (Stelara) for treating moderately to severely active ulcerative colitis in adults

Type

Technology appraisal guidance

Published

17 June 2020

NICE is unable to make a recommendation on daratumumab (Darzalex) with lenalidomide and dexamethasone for untreated multiple myeloma, because Janssen did not

Type

Technology appraisal guidance

Published

30 June 2020